Apresentação Pessoal
Ramon Andrade de Mello is a board certified medical oncologist in Portugal, Brazil and UK. He holds the Certificate in Medical Oncology by passing in the European examination of ESMO (European Society for Medical Oncology), Lugano, Switzerland, and in the Portuguese National Board Examination by the ACSS, Ministry of Health/Portuguese Medical Association, Lisbon, Portugal.
He completed specialization in medicine and molecular oncology and his PhD in Molecular Oncology (lung cancer) at the Faculty of Medicine, University of Porto, Portugal. He also completed the medical oncology training at Portuguese Oncology Institute, Porto, Portugal, supported by the ACSS, Ministry of Health, Lisbon, Portugal, and a clinical research fellowship in lung cancer clinical trials at the Lung Unit, Royal Marsden NHS Foundation Trust, Chelsea, London, United Kingdom, supported by the ESMO. He is Fellow Member of the American College of Physicians.
He was consultant medical oncologist at the Edinburgh Cancer Center, Western General Hospital, Edinburgh, UK. Currently, he is also Professor of Medical Oncology at School of Medicine, University of Algarve, Faro, Portugal, since 2013 and Federal University of São Paulo, Brazil, since 2019. Furthermore, he is honorary Professor of Medicine of the University of Porto since 2010. Professor De Mello performs both basic and clinical research on biomarkers, GI cancer and lung cancer; further, he has an active office working in medical oncology.
He is editor of 3 books (Tamoxifen Concepts and Cancer: New Paradigms and Vimentin Concepts and Molecular Mechanisms, Nova Science, NY, USA, 2013, and International Manual of Oncology Practice, Springer, Switzerland, 1st edition in 2015 and 2nd edition in 2019), author of several scientific articles, chapters and comments on basic and clinical research. He presented more than 50 papers in congresses and conferences in several countries, such as United States, Sweden, Denmark, Brazil, China, Bulgaria, Portugal and Spain. Furthermore, he serves as editorial board of several reputed scientific journals, such as PLoS ONE, Rare tumors, Oncology Reviews and scientific reviewer of the British Journal of Cancer, Journal of Thoracic Oncology, Annals of Internal Medicine and The Lancet. Prof. De Mello is ad hoc consultant for the Department of Sciences and Technology, Ministry of Health, Brasília, Brazil, expert reviewer at Netherlands Organization for Scientific Research (NOW), The Hague, Netherlands; and scientific advisory board for Pfizer, MSD and Zodiac.
Áreas de Interesse
- Health sciences > Medical sciences > Medicine > Clinical medicine
- Health sciences > Medical sciences > Medicine > Rare deseases
- Health sciences > Medical sciences > Medicine > Oncology